ArticleCurrent microbiology2025
Antagonistic Bacterial Endophytes from Gingers and their Metabolite Mediated Interactions Against Pythium Soft Rot.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Soft rot is the most devastating disease affecting ginger, leading to production losses of 50–90%. While chemical fungicides can effectively control this disease, their extensive use presents environmental and health risks. As an eco-friendly alternative, we evaluated bacterial endophytes and their bioactive compounds from wild ginger relatives to manage the soft rot pathogens Pythium myriotylum and P. deliense. Fifty endophytic bacteria from the leaves, rhizomes, and stems of the selected wild ginger relatives were isolated, and their antagonistic activity toward P. myriotylum and P. deliense was assessed using dual culture tests, of which 30 isolates showed greater than 50% inhibition against P. myriotylum, while 27 showed greater than 50% inhibition of P. deliense. Ten potential endophytic isolates were identified based on 16 S rRNA gene sequencing. Based on the antifungal assay and minimum inhibitory concentrations (MIC), the bacterial extracts of Pseudacidovorax intermedius (NCC15), Rhizobium sp. (NCC17A), Pseudomonas sp. (NCZ1), B. amyloliquefaciens (CC11) and B. pumilus (KG6) were selected for further studies. Scanning electron microscopy (SEM) analysis showed that the bacterial metabolite extract caused significant abnormalities in the hyphae and spores of Pythium spp., with P. myriotylum being more severely affected than P. deliense. Metabolic profiling of crude methanolic extracts revealed the presence of several antifungal compounds. Among them, four metabolites—Pyrrolo[1,2-a] pyrazine-1,4-dione, hexahydro-3-(phenylmethyl), N-(3-Imidazol-1-yl-propyl)-N’-(4-isopropyl-phenyl)-oxalamide [1,2,4], Oxadiazole, 5-benzyl-3-(thiophen-2-yl), and 2,5-Cyclohexadien-1-one, 3,5-dihydroxy-4,4- dimethyl were selected and docked with major Pythium proteins, yielded high docking scores, suggesting that these compounds possess anti-Pythium activity.
Indexed as
Identifiers
41261229What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.